In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...

The first phase of Honkai Star Rail 3.3 is nearing its end, and Trailblazers are eagerly waiting for the upcoming 5-star unit, Cipher. Your login session has expired.

Company’s PALISADE-4 Phase 3 trial now expected to read out in the first half of 2026. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical ...

Nepali royalists on Thursday launched a new phase of protest for the restoration of monarchy, which saw hundreds of people chant slogans on the street on the first day.

Pueblo West Metro Board swears in 3 new members. Board OK's Liberty Point maintenance agreement as part of upcoming Purcell Trail construction. Fire chief updates board on Fire Station No. 1 ...

A phase 1/2 open-label, multicenter, first-in-human study of the safety, tolerability, pharmacokinetics, and antitumor activity of BH-30643 in adult subjects with locally advanced or metastatic NSCLC ...

2024-25 stats: 19.9 ppg, 3.1 rpg, 2.7 apg, 0.9 spg, 42.7% FG, 39.7% 3FG Previous ranking: 3 Johnson has his flaws, but scoring and shooting certainly aren't one of them. He has an ability to light ...

Phase 3 is the final portion of offseason workouts. It's also the first set of practices with offense vs. defense on-field work permitted. Phase 1 is limited to rehab, meetings and conditioning.

The SERENITY At-Home Phase 3 trial is designed as a double-blind, placebo-controlled study to evaluate the safety of a 120 mcg dose of BXCL501 in 200 patients for acute treatment of agitation ...

San Francisco's third phase practices are slated to take place May 27-28, May 30, June 2-3 and June 5. Mandatory minicamp is scheduled for June 10-11. More 49ers: NFL analyst projects 49ers edge ...

Prothena today announced the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis did not meet its primary endpoint. ... Chair of Prothena’s Board of Directors.